Infections by multidrug resistant organisms (MDROs) are a global health threat with a worrying increasing trend. In fragile ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Most species of bacteria can be broadly divided into two groups, known as gram-positive and gram-negative. These categories reflect big differences in the microbes' biology, and they also dictate ...

AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

Early detection and public health interventions are critical in improving sepsis survival rates and limiting its long-term ...

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ...

All patients with suspected Gram-negative endocarditis should undergo transesophageal echocardiography (TEE) to confirm the diagnosis and assess for cardiac complications such as intracardiac ...

New research suggests that people with higher levels of a "good" bacteria in their guts also have lower levels of bacteria ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.